Patients who have recurrent infections require laboratory investigation for possible underlying immunode®ciency. We retrospectively evaluated the usefulness of two relevant assays (serum IgG subclass concentration and levels of IgG antigen-speci®c antibodies to a panel of relevant carbohydrate and protein antigens) in the management of patients referred to a regional clinical immunology service over a 3-year period. Of 97 patients for whom both assays were performed, ®ve (5´2%) had a low result for IgG subclasses but this did not in¯uence the management of any patient; 51 patients (53%) had a low result for antigen-speci®c antibodies and this in¯uenced management in 43 cases. We conclude that knowledge of the serum IgG subclass concentrations is of dubious relevance and this calls into question whether the assay should continue to be offered. This regional service has ceased to perform the assay routinely in such patients. Our ®ndings require con®rmation by a larger multicentre study that should assess the clinical outcome of any changes in practice.
INTRODUCTION
Patients with recurrent infections require immunological assessment in order to exclude underlying immunode®ciency and help inform their long-term management. The investigations indicated vary according to individual clinical features but frequently include assessment of humoral immunity, especially when sinopulmonary infections are present. When the serum total IgG concentration is found to be normal, it is conventional 1,2 to proceed to assay the individual serum IgG subclass concentrations (IgG 1±4 ) in order to pursue the possibility of de®ciency of one or more subclass. More recently, lacunar defects of humoral immunity have been described in which the serum concentrations of individual IgG subclasses are normal but there is an inability to produce antibodies of particular speci®cities 3, 4 (e.g. against certain polysaccharide antigens). For this reason, assays of IgG antigen-speci®c antibodies are now also performed, usually of IgG antibodies against tetanus, diphtheria, Haemophilusin¯uenzae b (Hib) and pneumococci.
Tetanus and diphtheria are chosen because they are protein antigens, and Hib and pneumococci because they are carbohydrate antigens from organisms that frequently cause infections at these sites, protein and carbohydrate antigens being handled differently by the normal immune system. Tetanus, diphtheria and Hib are administered routinely in UK childhood vaccination programmes, and a licensed pneumococcal vaccine (the 23-valent pneumovax) is also available.
Normal ranges of serum IgG subclass concentrations have been de®ned, as have those levels of IgG antibodies that are known to be protective 5±7 against tetanus, diphtheria and Hib infection. It has proved more dif®cult to de®ne protective ranges of antibodies against pneumococci in view of the large number of pathogenic serotypes, and the detailed assays that would be necessary to demonstrate protection to each one. Anti-pneumococcal antibodies are commonly absent or at very low levels in children aged under 7 years, and adult values are acquired only after a number of years. Moreover, there is great variation between individuals in the rates of acquisition of adult values of anti-carbohydrate antibodies. This is because carbohydrate antigens elicit antibody responses from B cells without the level of T-cell help that is available to protein antigens.
The above investigations for possible humoral immunode®ciency have become established owing to their availability and the de®nition of individual immunode®ciency conditions as described above. To our knowledge, no assessment of the value of performing IgG antigen-speci®c antibody assays has been published.
METHODS
Since 1 March 1995, details of all patients with suspected immunode®ciencies referred to the regional immunology service in Cardiff have been entered into a Microsoft Access database. In addition to essential patient identi®cation and source of request, the details recorded include clinical information at referral (from request forms, referral letters and clinical consultation), results of assays performed and interpretative comments made by the consultant clinical immunologist. Such comments were single clinical opinions, all of which were in consensus with specialist opinion in the ®eld. All records entered over an approximately 3-year period were checked in order to identify those patients who had had serum IgG subclass or IgG antigen-speci®c antibodies assayed. Records containing abnormal results were scrutinized in detail by the consultant clinical immunologist and an assessment was made of their clinical impact.
IgG subclasses were assayed by rate nephelometry on a Beckman Array analyser, the EQA performance being`good' for all four subclass assays (The UK National External Quality Assessment Scheme). IgG antigen-speci®c antibodies were assayed by enzyme-linked immunosorbent assay (ELISA) at the Department of Clinical Immunology, Oxford Radcliffe Hospital, in samples sent by post. The ELISA methods used have previously been described as follows: tetanus, 8 diphtheria, 8 Hib, 9,10 pneumococcal polysaccharides. 10, 11 There was no national EQA scheme for the latter during the period of the study, although a pilot scheme has recently been started.
The age-speci®c normal ranges for IgG subclasses were those used by the UK Protein Reference Units. 12 IgG antigen-speci®c antibodies against tetanus, diphtheria and Hib were considered normal or abnormal in relation to the levels that are associated with protection from infection. 12±14 In the absence of information about levels of antibodies associated with protection from infection, we considered pneumococcal antibodies to be abnormal if < 7% in children aged between 3±6 years, < 12% in those aged 6±9 years, < 15% in those aged 9±12 years and < 20% in those aged >12 years; no interpretation was made in children aged < 3 years. These percentages are the optical density (OD) values of the ELISA test serum (minus a blank, low-OD negative serum) divided by that of a known positive preparation (minus the same blank). 11 They have been slightly interpolated from the published data in order for the age ranges to concur with those available for IgG subclass concentration normal ranges.
RESULTS
Between 1 March 1995 and 31 April 1998, 565 records were entered into the database, of which 165 had either IgG subclasses or IgG antigen-speci®c antibodies determined and 97 had both. For all IgG subclass assays, all four IgG subclasses were assayed. All four IgG antigen-speci®c antibody determinations were performed on 91 of the above 97 samples, the remaining six samples being assayed for three of the four IgG antigen-speci®c antibodies.
Details of the IgG antigen-speci®c antibody results for these 97 patients are summarized in Table 1 . Fifty-one patients (51/97=53%) had low levels of one or more of the IgG antigen-speci®c antibodies: 13 were aged 0±5 years, 10 were aged 5±10 years, 8 were aged 10±15 years and 20 were aged 15±65 years. In 43 patients these results in¯uenced the management of the patient.
Five patients (5/97=5´2%) had low IgG subclass results, the IgG 2 concentration being low in each case. Four of these had normal results for antibodies against tetanus, diphtheria and Hib and low levels against pneumococci. The ®fth patient (aged 37 years) had low levels of antibodies against Hib, tetanus and diphtheria and normal levels against pneumococci. None of these subclass results signi®cantly affected the management of the patient. Table 2 shows relevant details.
DISCUSSION
From a population served of 2´27 million, 565 patients with suspected immunode®ciency were referred in a 3-year period. Antibody tests were considered to be indicated on clinical grounds by requesting consultants in 165 patients (29% of Evaluation of assays of serum IgG subclasses and IgG antigen-speci®c antibodies cases), there having been prior discussion of the cases with a consultant immunologist in most cases. Of the 97 patients who had both IgG subclass and IgG antigen-speci®c assays performed, 46 were resident in the local (Bro Taf) health authority. Thirty-two were seen by the consultant at the immunology outpatient clinic, 49 were samples sent from consultant paediatricians, 11 from consultant physicians, three from general practitioners and two from consultant surgeons.
Only ®ve patients (5´2%) had low subclass results, all being low IgG 2 . No patients were identi®ed with IgG 1 , IgG 3 or IgG 4 de®ciency. All ®ve patients had a low result for at least one IgG antigen-speci®c antibody, and none of these abnormal IgG 2 subclass results were considered to have additionally in¯uenced the clinical advice given to the requesting clinician. This calls into question the need to perform IgG subclass assays in addition to IgG antigen-speci®c assays. There is an inconsistent relationship between serum IgG 2 subclass de®ciency and immunocompetence against carbohydrate antigens. 13 There is a case for continuing to perform assays of IgG 2 because anti-polysaccharide antibody responses in adults are predominantly of this subclass. Whether assay of IgG antibodies against Hib and pneumococci would be reliable surrogate markers of IgG 2 subclass de®ciency in adults and children, however, remains uncertain. In our laboratory, assays of all four IgG subclasses cost £24. Those for all four IgG antigen-speci®c antibodies cost £53.
The abnormal IgG antigen-speci®c results found in 51 patients affected their management in that vaccination and checking the humoral response in blood taken 4 weeks later was advised in 27 cases, regular prophylactic antibiotic treatment in one case and intravenous immunoglobulin treatment in two cases. The remaining cases comprised family studies of nine relatives of immunode®cient patients, seven patients for whom no further treatment was recommended as other unrelated diagnoses for their symptoms were reached, three patients with DiGeorge anomaly, one with myeloma and one with ataxia telangiectasia.
The purpose of performing these assays was to investigate patients with recurrent infections for possible underlying antibody de®ciency. Only two patients (aged 30 and 34 years) had low levels of antibodies against diphtheria as the only abnormal IgG antigen-speci®c antibody result, and in neither case did this ®nding have any impact on the advice given regarding their management. This calls into question the value of assaying for antibodies against diphtheria in addition to those against tetanus in these patients.
In the UK, most immunologists consider serum IgG subclass concentration assay to be an essential ®rst-line investigation for patients with suspected primary antibody de®ciency, 14 but would choose not to measure subclass levels if the serum total IgG concentration were < 3 g/L. The Consensus Document for the Diagnosis and Management of Patients with Primary Antibody De®ciencies 15 supports the value of IgG subclass measurements.
However, the WHO consensus on investigation, diagnosis and classi®cation of primary immunode®ciency diseases 16 does point out that IgG subclass determination is of limited value in assessing patients with clinical immuno-de®ciency, since functional antibody de®ciency may be present despite normal IgG subclass levels, and conversely de®cient levels of a single subclass of IgG may be found in individuals who have effective speci®c antibody production and are clinically normal'.
Many clinical studies of larger numbers of patients have also called into question the usefulness of IgG subclass estimation. 10, 17, 18 Our evaluation supports the conclusions of the above studies and indicates the need to perform a large audit, which should include clinical follow-up of the patients studied in order to be able to relate these investigative aspects of patient management to clinical outcome. We suggest that newer, more original investigations need to be developed that test the biological function of these antibodies (e.g. in opsonophagocytosis) rather than merely their concentration in a binding assay.
